The Lancet

When to and when not to use machine learning in risk prediction models

Machine learning for health data science, fuelled by proliferation of data and reduced computational costs, has garnered ...
The American Journal of Managed Care

Machine Learning May Enable Earlier Detection of CKD Risk Factors

Both approaches identified hemoglobin as one of the most significant predictors of CKD risk. Additional top-ranked features included blood urea, sodium levels, red blood cell count, potassium, and ...
TMCnet

Data Normalization vs. Standardization: What's the Difference and When to Use Each

Data Normalization vs. Standardization is one of the most foundational yet often misunderstood topics in machine learning and ...
CIO

Predicting the future is easy — deciding what to do is the hard part

AI agents help businesses stop guessing — linking predictions to actions so teams can move from “what might happen” to “here’s what to do.” ...
Open Heart

Enhanced cardiovascular disease risk prediction using integrated machine learning models: a study from the UK Biobank cohort

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk ...
AHA/ASA Journals

Multistage Electrocardiographic Profiling for Mental Stress-Induced Myocardial Ischemia in Women: A Prospective, Age-Matched Cohort Study in China

BACKGROUND: Mental stress-induced myocardial ischemia is often clinically silent and associated with increased cardiovascular risk, particularly in women. Conventional ECG-based detection is limited, ...
Psychology Today

Diagnosing Schizophrenia With Machine Learning

Machine learning can predict many things, but can it predict who will develop schizophrenia years before the average ...
Harvard Business Review

When Every Company Can Use the Same AI Models, Context Becomes a Competitive Advantage

When everyone has access to the same AI models, the same AI-enabled tools, and the same vendor ecosystem, organizational context becomes the differentiator. Context is demonstrated execution: the ...
AHA/ASA Journals

Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design

BACKGROUND: BCR-ABL tyrosine kinase inhibitors (TKIs) have been increasingly linked to pulmonary arterial hypertension (PAH) since 2009, although supporting evidence is limited. Our objective was to ...